BIORESTORATIVE THERAPIES, INC. Payments to Acquire Marketable Securities
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Payments to Acquire Marketable Securities of $74.92 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-05-14
- BIORESTORATIVE THERAPIES, INC. payments to acquire marketable securities for the quarter ending 2026-03-31 was $74.92K, a 92.89% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. payments to acquire marketable securities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. payments to acquire marketable securities for the quarter ending 2025-09-30 was $550.47K, a 90.01% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. payments to acquire marketable securities for the quarter ending 2025-06-30 was $1.08M, a 47.70% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. payments to acquire marketable securities for fiscal 2025 was $2.68M, a 87.17% decline from fiscal 2024.
- BIORESTORATIVE THERAPIES, INC. payments to acquire marketable securities for fiscal 2024 was $20.89M, a 19.08% increase from fiscal 2023.
- BIORESTORATIVE THERAPIES, INC. payments to acquire marketable securities for fiscal 2023 was $17.54M, a 21.87% decline from fiscal 2022.
- BIORESTORATIVE THERAPIES, INC. payments to acquire marketable securities for fiscal 2022 was $22.45M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 9 month as first filed | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74.92K 10-Q · filed 2026-05-14 | $74.92K derived: sum of 2 quarters · filed 2026-05-14 | $625.39K derived: sum of 3 quarters · filed 2026-05-14 | $1.70M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $550.47K derived: sum of 2 quarters · filed 2026-03-26 | $1.63M derived: sum of 3 quarters · filed 2026-03-26 | $2.68M 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $550.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.63M derived: sum of 2 quarters · filed 2025-11-12 | $2.68M 10-Q · filed 2025-11-12 | $5.27M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2025-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.13M 10-Q · filed 2025-08-12 | $4.72M derived: sum of 3 quarters · filed 2026-05-14 | $10.23M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2025-03-31 | $1.05M 10-Q · filed 2026-05-14 | $3.65M derived: sum of 2 quarters · filed 2026-05-14 | $9.16M derived: sum of 3 quarters · filed 2026-05-14 | $11.21M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $8.10M derived: sum of 2 quarters · filed 2026-03-26 | $10.16M derived: sum of 3 quarters · filed 2026-03-26 | $20.89M 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $7.57M derived: sum of 2 quarters · filed 2025-11-12 | $18.29M 10-Q · filed 2025-11-12 | $21.18M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $12.78M 10-Q · filed 2025-08-12 | $15.67M derived: sum of 3 quarters · filed 2025-08-12 | $22.79M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $10.73M 10-Q · filed 2025-05-14 | $13.62M derived: sum of 2 quarters · filed 2025-05-14 | $20.73M derived: sum of 3 quarters · filed 2025-05-14 | $26.80M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $10.01M derived: sum of 2 quarters · filed 2025-03-28 | $16.07M derived: sum of 3 quarters · filed 2025-03-28 | $17.54M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $7.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $13.18M derived: sum of 2 quarters · filed 2024-11-12 | $14.65M 10-Q · filed 2024-11-12 | $437.84K 10-Q · filed 2023-11-13 | $27.17M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $7.54M 10-Q · filed 2024-08-13 | $20.05M derived: sum of 3 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $1.47M 10-Q · filed 2024-06-11 | $13.99M derived: sum of 2 quarters · filed 2024-06-11 | ||||
| 2022-12-31 | $12.52M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-11 | $22.45M 10-K/A · filed 2024-06-11 | $13.04M 10-K · filed 2023-03-27 | |||
| 2022-09-30 | $9.93M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |